Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Clinical spectrum of hereditary hemorrhagic telangiectasia (HHT): Data from the comprehensive hht outcomes registry of the United States (CHORUS)

Blood (2025) 146 (Supplement 1): 309.

https://doi.org/10.1182/blood-2025-309

Published: 2025

Journal Articles

Myeloid-derived suppressor cells are expanded in the antiphospholipid antibody syndrome

Anne Hubben, Maierdan Palihati, Charles Sukin, Keith McCrae

Blood (2025) 146 (Supplement 1): 3101.

https://doi.org/10.1182/blood-2025-3101

Published: 2025

Journal Articles

COVID-19 IgG antibodies drive endothelial cell activation and dysfunction

Bhagwati Joshi, Charles Sukin, Wolfram Ruf, Keith McCrae

Blood (2025) 146 (Supplement 1): 3096.

https://doi.org/10.1182/blood-2025-3096

Published: 2025

Journal Articles

Targeted metabolomics identifies a metabolic switch to mitochondrial respiration in antiphospholipid syndrome that drives platelet procoagulant activity

Paresh Kulkarni, Maierdan Palihati, Anne Hubben, Keith McCrae

Blood (2025) 146 (Supplement 1): 4790.

https://doi.org/10.1182/blood-2025-4790

Published: 2025

Journal Articles

Plasma protein biomarkers associated with venous thromboembolism (VTE) and mortality in patients with cancer: A substudy of the avert trial

Mehrie Patel, John Barnard, Marc Carrier, Philip Wells, Keith McCrae, Alok Khorana

Blood (2025) 146 (Supplement 1): 3127.

https://doi.org/10.1182/blood-2025-3127

Published: 2025

Journal Articles

Enhanced procoagulant activity of phosphatidylserine-positive platelets in antiphospholipid syndrome

Charles Sukin, Paresh Kulkarni, Anne Hubben, Bhagwati Joshi, Michael Cole, Dana Angelini, Sandra Mazzoni, Robert Brodsky, Keith McCrae

Blood (2025) 146 (Supplement 1): 1249.

https://doi.org/10.1182/blood-2025-1249

Published: 2025

Journal Articles

Complement-induced procoagulant platelets in patients with antiphospholipid antibodies

Paresh Kulkarni, Maierdan Palihati, Anne Hubben, Michael Cole, Bhagwati Joshi, Dana Angelini, Sandra Mazzoni, Shruti Chaturvedi, Robert Brodsky, Keith McCrae

Blood (2025) 146 (Supplement 1): 416.

https://doi.org/10.1182/blood-2025-416

Published: 2025

Journal Articles

Inositol hexakisphosphate kinase 1 (IP6K1)-driven tumor polyphosphate may contribute to immune checkpoint inhibitor-associated thrombosis

Young Jun Shim, Alok Khorana, Keith McCrae

Blood (2025) 146 (Supplement 1): 202.

https://doi.org/10.1182/blood-2025-202

Published: 2025

Journal Articles

Antiphospholipid syndrome (APS) is the newest member of the PF4 immunothrombotic family: Mechanistic and therapeutic insights

Amrita Sarkar, Conroy Field, Khalil Bdeir, Santosh Yadav, Kandace Gollomp, Keith McCrae, Thomas Ortel, Jason Knight, Jérôme Rollin, Yves Gruel, Gow Arepally, Lubica Rauova, Mortimer Poncz

Blood (2025) 146 (Supplement 1): 194.

https://doi.org/10.1182/blood-2025-194

Published: 2025

Journal Articles

A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain

Ivan Ivanov, Anton Matafonov, Mao-fu Sun, Bassem M. Mohammed, Qiufang Cheng, S. Kent Dickeson, Suman Kundu, Ingrid M. Verhamme, Andras Gruber, Keith McCrae, David Gailani

Blood (2019) 133 (10): 1152–1163.

https://doi.org/10.1182/blood-2018-06-860270

Published: 2019

Includes: Supplemental data

Journal Articles

Factors Associated with Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura: Results from the United States Thrombotic Microangiopathy TTP Registry

Todd Clover, MD MS, Ronald S. Go, MD, Ana G. Antun, MD, Spero R Cataland, MD, Shruti Chaturvedi, MBBS,MS, Elizabeth Davis, Andrew Johnson, MD, Ming Yeong Lim, MBBChir, Meera Sridharan, MD, Keith McCrae, MD, J. Evan Sadler, MD PhD, Marshall A. Mazepa, MD, Lisa Baumann-Kreuziger, MS MD

Blood (2017) 130 (Supplement 1): 3624.

https://doi.org/10.1182/blood.V130.Suppl_1.3624.3624

Published: 2017

Journal Articles

A Descriptive Analysis of the Demographics and Presenting Symptoms of Patients in the U.S. Thrombotic Microangiopathy (USTMA) TTP Registry

Elizabeth Davis, Ana G. Antun, MD, Lisa Baumann Kreuziger, MD MS, J. Evan Sadler, MD PhD, Spero R Cataland, MD, Meera Sridharan, MD, Todd Clover, MD, Andrew Johnson, MD, Keith McCrae, MD, Shruti Chaturvedi, MBBS,MS, Ronald S. Go, MD, Ming Yeong Lim, MBBChir, Marshall A. Mazepa, MD

Blood (2017) 130 (Supplement 1): 1049.

https://doi.org/10.1182/blood.V130.Suppl_1.1049.1049

Published: 2017

Journal Articles

RNA Sequencing Approaches to Identify Novel Biomarkers for Venous Thromboembolism (VTE) in Lung Cancer

Tamara A. Sussman, MD, Mohamed Abazeed, MD PhD, Keith McCrae, MD, Alok A. Khorana, MD

Blood (2017) 130 (Supplement 1): 554.

https://doi.org/10.1182/blood.V130.Suppl_1.554.554

Published: 2017

Journal Articles

Implementation of an Electronic Medical Record Tool for Early Detection of Deep Vein Thrombosis in the Ambulatory Oncology Setting: The Cleveland Clinic Experience

Girish Kunapareddy, MD, Benjamin Switzer, DO, MHSA, MS, Madison Conces, MD, Pramod Pinnamaneni, MD, Bhumika J. Patel, MD, Sagar S. Patel, MD, Alicia Redden, Dana E. Angelini, MD, Keith McCrae, MD, Brad Pohlman, MD, Alok A. Khorana, MD

Blood (2017) 130 (Supplement 1): 3361.

https://doi.org/10.1182/blood.V130.Suppl_1.3361.3361

Published: 2017

Journal Articles

The Impact of Detectable ADAMTS13 Inhibitor on the Clinical Presentation and Outcome of Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Analysis Using the United States Thrombotic Microangiopathy (USTMA) Clinical Registry

Meera Sridharan, MD, Ana G Antun, MD, Lisa Baumann Kreuziger, Assistant Professor. MD MS, Spero R Cataland, MD, Shruti Chaturvedi, MBBS,MS, Todd Clover, MD, Elizabeth Davis, Andrew Johnson, MD, Keith McCrae, MD, Ming Yeong Lim, MBBChir, J. Evan Sadler, MD PhD, Marshall A. Mazepa, MD, Ronald S Go, MD

Blood (2017) 130 (Supplement 1): 3620.

https://doi.org/10.1182/blood.V130.Suppl_1.3620.3620

Published: 2017

Journal Articles

Comparison of FXII Activation in Human Plasma By Extracellular Vesicles from Cancer Cells Versus Non-Transformed Cells

Dewen You, PhD, Victor Chatterjee, MD, Suman Kundu, MBA, Mohamed Samour, MBBS, Alvin H. Schmaier, MD, Alok A. Khorana, MD, Keith McCrae, MD

Blood (2017) 130 (Supplement 1): 3705.

https://doi.org/10.1182/blood.V130.Suppl_1.3705.3705

Published: 2017

Journal Articles

Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results

James B. Bussel, MD, Donald M Arnold, MD, Nichola Cooper, MA, MD MRCP, FRCPath, Alhossain A Khalafallah, MD, Michael Boxer, MD, Darla Liles, MD, Waleed Ghanima, MD PhD, Keith McCrae, MD, Hany Zayed, Benoit Cadieux, PhD, Anne-Marie Duliege, MDMS

Blood (2017) 130 (Supplement 1): 16.

https://doi.org/10.1182/blood.V130.Suppl_1.16.16

Published: 2017

Journal Articles

A Novel Immunoblot Assay to Detect Contact Activation in Patients with Cancer

Dewen You, PhD, Victor Chatterjee, MD, Mohamed Samour, MBBS, Suman Kundu, MBA, Alvin H. Schmaier, MD, Alok A. Khorana, MD, Keith McCrae, MD

Blood (2017) 130 (Supplement 1): 2385.

https://doi.org/10.1182/blood.V130.Suppl_1.2385.2385

Published: 2017

Journal Articles

High Molecular Weight Kininogen Alters the Tumor Microenvironment and Reduces Tumor Stem Cell Content

Meenal Shukla, James Hale, PhD, Justin Lathia, PhD, Keith McCrae, MD

Blood (2017) 130 (Supplement 1): 2340.

https://doi.org/10.1182/blood.V130.Suppl_1.2340.2340

Published: 2017

Journal Articles

Cancer Cell-Derived Extracellular Vesicles Are Prothrombotic in an in-Vitro Vessel Model

Victor Chatterjee, MD, Mohamed Samour, MBBS, Dewen You, PhD, Suman Kundu, MBA, Alok A. Khorana, MD, Keith McCrae, MD

Blood (2017) 130 (Supplement 1): 2308.

https://doi.org/10.1182/blood.V130.Suppl_1.2308.2308

Published: 2017

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Clinical spectrum of hereditary hemorrhagic telangiectasia (HHT): Data from the comprehensive hht outcomes registry of the United States (CHORUS)

Myeloid-derived suppressor cells are expanded in the antiphospholipid antibody syndrome

COVID-19 IgG antibodies drive endothelial cell activation and dysfunction

Targeted metabolomics identifies a metabolic switch to mitochondrial respiration in antiphospholipid syndrome that drives platelet procoagulant activity

Plasma protein biomarkers associated with venous thromboembolism (VTE) and mortality in patients with cancer: A substudy of the avert trial

Enhanced procoagulant activity of phosphatidylserine-positive platelets in antiphospholipid syndrome

Complement-induced procoagulant platelets in patients with antiphospholipid antibodies

Inositol hexakisphosphate kinase 1 (IP6K1)-driven tumor polyphosphate may contribute to immune checkpoint inhibitor-associated thrombosis

Antiphospholipid syndrome (APS) is the newest member of the PF4 immunothrombotic family: Mechanistic and therapeutic insights

A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain

Factors Associated with Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura: Results from the United States Thrombotic Microangiopathy TTP Registry

A Descriptive Analysis of the Demographics and Presenting Symptoms of Patients in the U.S. Thrombotic Microangiopathy (USTMA) TTP Registry

RNA Sequencing Approaches to Identify Novel Biomarkers for Venous Thromboembolism (VTE) in Lung Cancer

Implementation of an Electronic Medical Record Tool for Early Detection of Deep Vein Thrombosis in the Ambulatory Oncology Setting: The Cleveland Clinic Experience

The Impact of Detectable ADAMTS13 Inhibitor on the Clinical Presentation and Outcome of Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Analysis Using the United States Thrombotic Microangiopathy (USTMA) Clinical Registry

Comparison of FXII Activation in Human Plasma By Extracellular Vesicles from Cancer Cells Versus Non-Transformed Cells

Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results

A Novel Immunoblot Assay to Detect Contact Activation in Patients with Cancer

High Molecular Weight Kininogen Alters the Tumor Microenvironment and Reduces Tumor Stem Cell Content

Cancer Cell-Derived Extracellular Vesicles Are Prothrombotic in an in-Vitro Vessel Model

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only